+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis



MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis



Journal of Virology 78(12): 6449-6458



Virus infection of the central nervous system (CNS) often results in chemokine upregulation. Although often associated with lymphocyte recruitment, increased chemokine expression is also associated with non-lymphocyte-mediated CNS disease. In these instances, the effect of chemokine upregulation on neurological disease is unclear. In vitro, several chemokines including monocyte chemotactic protein 1 (MCP-1) protect neurons from apoptosis. Therefore, in vivo, chemokine upregulation may be a protective host response to CNS damage. Alternatively, chemokines may contribute to pathogenesis by stimulating intrinsic brain cells or recruiting macrophages to the brain. To investigate these possibilities, we studied a neurovirulent retrovirus, Fr98, that induces severe non-lymphocyte-mediated neurological disease and causes the upregulation of several chemokines that bind to chemokine receptors CCR2 and CCR5. Knockout mice deficient in CCR2 had reduced susceptibility to Fr98 pathogenesis, with significantly fewer mice developing clinical disease than did wild-type controls. In contrast, no reduction in Fr98-induced disease was observed in CCR5 knockout mice. Thus, signaling through CCR2, but not CCR5, plays an important role in Fr98-mediated pathogenesis. Three ligands for CCR2 (MCP-1, MCP-3, and MCP-5) were upregulated during Fr98 infection of the brain. Antibody-blocking experiments demonstrated that MCP-1 was important for retrovirus-induced neurological disease. In situ hybridization analysis revealed that MCP-1 was expressed by glial fibrillary acidic protein-positive astrocytes. Thus, astrocytes, previously not thought to play an effector role in the disease process were found to contribute to pathogenesis through the production of MCP-1. This study also demonstrates that chemokines can mediate pathogenesis in the CNS in the absence of lymphocytic infiltrate and gives credence to the hypothesis that chemokine upregulation is a mechanism by which retroviruses such as human immunodeficiency virus induce neurological damage.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012279449

Download citation: RISBibTeXText

PMID: 15163738

DOI: 10.1128/jvi.78.12.6449-6458.2004


Related references

The role of cytokines and chemokines in neurological disease induced by polytropic retrovirus infection in mice. Journal of Neurovirology 8(Suppl. 1): 61, 2002

Characterization of a neurologic disease induced by a polytropic murine retrovirus: evidence for differential targeting of ecotropic and polytropic viruses in the brain. Journal of Virology 69(12): 8070-8075, 1995

Toll-like receptor 7 is not necessary for retroviral neuropathogenesis but does contribute to virus-induced neuroinflammation. Journal of Neurovirology 14(6): 492-502, 2008

Two separate envelope regions influence induction of brain disease by a polytropic murine retrovirus (FMCF98). Journal of Virology 70(7): 4825-4828, 1996

Co-immunization of mice with a retroviral DNA vaccine and GITRL-encoding plasmid augments vaccine-induced protection against retrovirus infection. Viral Immunology 21(4): 459-467, 2008

Host genes conferring resistance to a central nervous system disease induced by a polytropic recombinant Friend murine retrovirus. Journal of Virology 64(2): 493-498, 1990

Interferon-mediated inhibition of retroviral infection: use of a defective retrovirus carrying a drug-resistance gene. Virus Research 13(4): 295-302, 1989

Retrovirus-induced lymphoproliferative disease in mice: role of humoral immunity in perinatally exposed mice. Immunobiology 194(4-5): 390-402, 1995

Innate immunity in the pathogenesis of polytropic retrovirus infection in the central nervous system. Immunologic Research 43(1-3): 149-159, 2009

Susceptibility of neonatal brain astrocytes to retroviral infection following ethanol exposure. International Journal of Developmental Neuroscience 14(Suppl. 1): 96, 1996

Infection of cardiomyocytes and induction of left ventricle dysfunction by neurovirulent polytropic murine retrovirus. Journal of Virology 81(22): 12307-12315, 2007

Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions. Molecular and Cellular Biology 12(4): 1755-1763, 1992

Prevention of retrovirus-induced neurological disease by infection with a nonneuropathogenic retrovirus. Virology 206(1): 372-380, 1995

Class II polytropic murine leukemia viruses (MuLVs) of AKR/J mice: possible role in the generation of class I oncogenic polytropic MuLVs. Journal of Virology 61(6): 1882-1892, 1987

Restoration of T and B lymphocyte development in RAG-2 deficient mice by retroviral mediated gene transfer. Blood 98(11 Part 1): 214a, 2001